Circulating Tumour Cell-Derived Plastin3 Is a Novel Marker for Predicting Long-Term Prognosis in Patients With Breast Cancer

British Journal of Cancer - United Kingdom
doi 10.1038/bjc.2015.132
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Early Postoperative Circulating miR-483-5p Is a Prognosis Marker for Adrenocortical Cancer

Cancers
Cancer ResearchOncology
2020English

The Nutritional Index ‘CONUT’ Is Useful for Predicting Long-Term Prognosis of Patients With End-Stage Liver Diseases

Tohoku Journal of Experimental Medicine
BiochemistryMedicineGeneticsMolecular Biology
2011English

Circulating Cell-Free DNA and Its Integrity as a Prognostic Marker for Breast Cancer

SpringerPlus
Multidisciplinary
2015English

USP22 Is Useful as a Novel Molecular Marker for Predicting Disease Progression and Patient Prognosis of Oral Squamous Cell Carcinoma

PLoS ONE
Multidisciplinary
2012English

NOTCH4 Is a Novel Prognostic Marker That Correlates With Colorectal Cancer Progression and Prognosis

Journal of Cancer
Oncology
2018English

Predicting Long‐term Prognosis in Severe Alcoholic Hepatitis

Liver International
Hepatology
2020English

SPOCK1 Is a Novel Transforming Growth Factor-Β–Induced Myoepithelial Marker That Enhances Invasion and Correlates With Poor Prognosis in Breast Cancer

PLoS ONE
Multidisciplinary
2016English

The Clinical Utility of Circulating Tumour Cells in Patients With Small Cell Lung Cancer

Translational Lung Cancer Research
Oncology
2017English

Chitotriosidase, a Marker of Innate Immunity, Is Elevated in Patients With Primary Breast Cancer

Cancer Biomarkers
MedicineCancer ResearchOncologyGenetics
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy